A systems medicine network

e:Med

Summer Schools - now online

Applications for the e:Med summer schools 2019 are now open. The first deadlines are already in January 2019. More information on the different e:Med summer schools can be found here.

Demonstrators

How to find the optimal dose with mathematical modelling

Specific targeted therapies are commonly used for blood cancer patients suffering from chronic myeloid leukemia (CML). Although these medications are very effective, most patients need to take these drugs their whole life. Reducing the dosage and adapting it to each patient individually is the goal of a mathematical model developed by systems medicine scientists from Dresden.

e:Med

Personalized Medicine Day

The "Personalized Medicine Day" in Berlin was a great success! 400 pupils, students, scientists and interested citizens have come to the Urania and have obtained information through lectures and interactive experiments on the current research of personalized medicine.

Demonstrators

With diabetes medication against Parkinson’s disease

For some patients, suffering from a specific type of Parkinson, a diabetic medication could help to stop disease progression. This new approach is investigated by Julia Fitzgerald and colleagues from the Hertie-Instiute in Tuebingen.

Consortia

Detecting early warning signs and disease transition in alcohol addiction

e:Med researchers from the SysMedAlcoholism consortium and their cooperation partners at the University of Tokyo found out for the first time by means of a new computational approach that the transition into an addictive drinking behavior are preceded by predictive "early warning signals". The analytical approach to elaborate longitudinal data has the potential to predict the onset of illness and changes in various stages of the disease in the state of health.

Consortia

Schizophrenia risk mutations lead to instable neuronal networks

How does Schizophrenia work on the molecular level? In this study, dynamic network neuroscience techniques and neuroimaging methods were applied by scientists of the e:Med consortia IntegraMent to uncover the molecular and genetic contributions of glutamate and brain network dynamics.

Consortia

Beta cells under fire

Type 2 diabetes causes pathological changes in the beta cells. Scientists have successfully depicted the processes on the basis of the metabolome and proteome for the first time. Their work has been published in Cell Metabolism.

Junior research alliances and consortia

The importance of being genotyped

Small cell lung cancer is an aggressive type of cancer and can progress in very different, individual ways but so far no targeted therapy has been approved. By designing a mouse model mimicking a human disease phenotype, scientists of the e:Med alliances MILES & SMOOSE discovered a promising combination therapy.

Junior Research Group

Hamid Noori receives animal welfare award

The Deutsche Forschungsgemeinschaft awarded the Ursula M. Händel Animal Welfare Prize of to PD Dr. Dr. Hamid Noori. The e: Med Junior Research Group Leader is a scientist at the Max Planck Institute for Biological Cybernetics in Tübingen, where he and his team have developed a database and computer models that can predict the effects of novel substances on the rat brain. As a result, new studies can be designed more purposefully, avoiding unnecessary animal experiments.

e:Med project groups - overlapping issues in focus

Scientists discuss new technologies and latest scientific contents and launch comprehensive initiatives in four e:Med project groups (PG) regarding substantially and methodologically overlapping systems medicine issues. The objective of the PG is to promote interactions between members and handle relevant issues across the research group.